| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Pliant Therapeutics, Inc. (PLRX) has 13 insiders with recent SEC Form 4 filings, including 0 buys and 14 sells. PLRX is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 505.6K | $619.4K | - | |
| CFO | 297.2K | $364.1K | - | |
| Other | 44.8K | $54.9K | - | |
| COO | 37.8K | $46.3K | - | |
| Dir | 30.0K | $36.8K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 4, 2023 | Hull Hans79 | Chief Business Officer | Sale+OE | 34,919 | $20.01 | $698,580.50 | -5.4% | -25.4% | -31.2% | |
| Jul 20, 2023 | Ouimette Mike81 | General Counsel &Corp. Sec'y | Sell | 4,755 | $17.55 | $83,450.25 | -7.3% | -22.6% | -29.4% | |
| Jul 17, 2023 | Ouimette Mike81 | General Counsel &Corp. Sec'y | Sell | 12,778 | $18.01 | $230,120.28 | -16.4% | -13.7% | -24.3% | |
| Jul 17, 2023 | Lefebvre Eric82 | Chief Medical Officer | Sell | 22,321 | $18.01 | $401,981.12 | -11.8% | -13.7% | -24.3% | |
| Jul 17, 2023 | Hull Hans79 | Chief Business Officer | Sell | 17,937 | $18.01 | $323,029.23 | -7.6% | -13.7% | -24.3% | |
| Jul 17, 2023 | Cummings Keith Lamont74 | Chief Financial Officer | Sell | 19,771 | $18.01 | $356,057.92 | -8.8% | -13.7% | -24.3% | |
| Jul 17, 2023 | Coulie Bernard80 | President And CEO | Sell | 70,150 | $18.01 | $1,263,338.37 | -17.0% | -13.7% | -24.3% | |
| Apr 3, 2023 | Ouimette Mike81 | General Counsel &Corp. Sec'y | Sell | 7,751 | $26.62 | $206,329.08 | -4.7% | -32.0% | -44.6% | |
| Mar 30, 2023 | Lefebvre Eric82 | Chief Medical Officer | Sell | 11,245 | $26.52 | $298,227.52 | -7.2% | -28.3% | -43.9% | |
| Mar 30, 2023 | Hull Hans79 | Chief Business Officer | Sell | 9,036 | $26.52 | $239,642.85 | -4.3% | -28.3% | -43.9% |